Intra-Axial Brain Tumors
Intra-Axial Brain Tumors
Intra-Axial Brain Tumors
net/publication/8104148
CITATIONS READS
23 12,610
3 authors, including:
All content following this page was uploaded by Stefan Sunaert on 09 December 2015.
G. Wilms
Ph. Demaerel
Intra-axial brain tumours
S. Sunaert
fully examined. These steps are: detection, evaluation of its brain on CT (Fig. 1a). Artefacts in the posterior fossa or on
effect on the brain and the ventricles, localisation especially the highest slices can mask subtle lesions [15].
with regard to eloquent areas and definition of the extent With MRI, detection will depend on the difference in
of the tumour. Finally the type and grade of the tumour MRI characteristics, such as T1, T2, proton density, flow,
have to be described, together with its differential diagno- etc. It is known that the sensitivity for pathological con-
sis, especially with non-tumoural lesions. ditions is higher with MR than with CT. Lesions producing
The first and of course limiting step is the detection of little or no change in CT density tend to be more con-
an intracerebral mass. This will first depend on the volume spicuous on MR (Fig. 1b) [15]. This is due to the high
of the lesion: smaller lesions will be more easily missed than sensitivity of MR for changes in water content, almost in-
larger ones. Nowadays with appropriate techniques and variably present in or accompanying brain tumours, leading
proper clinical suspicion, very small lesions such as tiny to hyperintensity on T2-images and FLAIR images. Isoin-
metastases or microadenomas of the hypophysis can be tensity of a lesion is extremely infrequent with higher field
detected with CT. Detection will depend on the difference in magnets and, if seen, is rarely present on all sequences.
CT characteristics, meaning the atomic number or radio- Small metastasis, though, still can be missed if only a
density. Tumours such as low grade glioma, metastasis or screening transaxial T2-weighted sequence is performed.
lymphoma can be almost isodense with the surrounding If contrast medium is administered, detection will de-
pend on the difference in vascularity and on the damage to
is confined to one lobe or extends over a fissure to an- specification of the nature of the lesion. We have to dif-
other lobe (for instance, a frontotemporal lesion) (Fig. 5), ferentiate between primary and metastatic lesions, menin-
if the tumour involves the brain stem, basal ganglia, crosses gioma and neurinoma, lymphoma and metastasis, benign
the midline, extends through the incisura tentorii, through and malignant character, glioma and other kinds of brain
the foramen magnum or seeds to specific anatomic areas. In tumours. This differential diagnosis is based on CT or MR
this regard, the metastasis of pineoblastoma to the infun- characteristics (density-intensity), extension or localisation,
dibulum of the hypophysis is a pathognomonic finding in contrast enhancement and classical signs [19, 20].
a patient with diabetes insipidus (Fig. 6). Here too, mul- The first is the CT density of the lesion or the intensity
tiplanar imaging with MRI, with depiction of the ana- on MR. The presence of calcification can point to oligo-
tomic relations in the axial, coronal and sagittal planes, is dendroglioma or ependymoma. Flow voids because of
mandatory. hypertrophic draining veins or hypervascularity can sug-
The final step in the examination of patients with a gest hemangioblastoma (Fig. 7). The signal from cystic
cerebral mass lesion is the differential diagnosis or the components, such as hyperintense cholesterol-containing
Fig. 14 Importance of perfusion MR in tumour grading. Thirty- benate dimeglumine (MultiHance) at an injection rate of 4 ml/s.
four-year-old female patient presenting with a histologically proven Time-to-bolus arrival (T0), time-to-peak (TTP), regional cerebral
oligodendroglioma grade 3 in the right frontal lobe, and a second blood volume (NI), regional cerebral perfusion (index) and mean-
focal lesion in the right temporal pole, with “gliosis” as histological transit-time (MTT) maps were calculated. Perfusion characteristics
diagnosis. Dynamic contrast-enhanced T2* MR perfusion imaging of the frontal grade 3 oligodendroglioma show markedly increased
was performed at 3T with a GE-EPI perfusion sequence with a rCBV and rCBF within most of the tumour A. The temporal area of
temporal resolution of 1.5 s and injection of 0.1 mmol/kg gabo- gliosis has normal to slightly decreased rCBV and rCBF B
The radiological diagnosis of intra-axial brain tumours from the tumour volume and by crossing the borders of the
cerebral lobes (Fig. 12a, b).
Here, we will discuss the imaging aspects of the most fre- Progressive malignant transformation is characterised by
quent intra-axial tumours: the neuro-epithelial tumours, the a progressive increase in tumoral necrosis, intratumoral
embryonal tumours and the metastases. haemorrhage and peritumoural oedema, with appearance of
The World Health Organisation (WHO) Classification contrast enhancement. In this way the low-grade astrocyto-
of Brain Tumours was profoundly changed in 1993 and ma becomes anaplastic and finally displays the very “mul-
was updated recently in 2000 [28, 29]. For the typing and tiform” aspect of glioblastoma multiforme (Fig. 12c, d)
grading of brain tumours, no longer only standard patho- [20, 24]. It has to be stressed that in some gliomas anaplastic
logical features are used, but besides information on immu- transformation is not translated into an increase of contrast
nohistochemistry and genetics, imaging findings are taken enhancement [25].
into account. The peritumoural vasogenic oedema is typically “finger-
The most important change concerned the large group of like”, dissecting white matter tracts (Fig. 14a). This oede-
the astrocytic tumours, accounting for more than 60% of ma reflects the break-down of the blood-brain barrier, but
primary brain tumours. Here, a distinction is made between is also related to angiogenesis, as proven by the presence
diffusely infiltrating and circumscribed astrocytomas, re- of vascular endothelial growth factors (VEGF). There-
ferring to both gross pathological and imaging features. fore, oedema is more pronounced in malignant tumours
The diffusely infiltrating astrocytomas are at least grade 2 [30, 31].
and have an inherent tendency for anaplastic progression. Tumoral contrast enhancement is mostly anarchic, areas
Circumscribed astrocytomas are benign, and malignant of homogeneous enhancement alternating with ringlike
transformation is extremely rare. bands of enhancement with nodular formations in the wall
Low grade astrocytomas are hypodense on CT and have (Fig. 13b). It reflects both the blood-brain barrier break-
long T1 and T2 on MRI. Classically, there is no contrast down, but also is correlated with tumoral angiogenesis.
enhancement. The diffusely infiltrating character is reflect- This “malignant hypervascularity” has been known for a
ed in a replacement rather than a displacement of brain long time from angiography, but is now easily demon-
structures leading to a mass-effect that is less then expected strated by perfusion CT or MRI [5–7] (Fig. 14a). Demon-
477
Fig. 17 Oligodendroglioma
grade 2: CT and MR-aspect of
calcifications. Enhancement in
a low-grade lesion. a Contrast-
enhanced CT scan: space-
occupying lesion in the left
parieto-occipital area with ante-
rior displacement of the calci-
fied choroid plexus of the left
lateral ventricle. Presence of
dense streaky calcifications
(arrow) in the lesion. Moderate
enhancement of the dorsal as-
pect of the lesion. b Transverse
T2-weighted MR image: the
lesion is inhomogeneously hy-
perintense. The calcifications
are seen as hypointense streaks
(arrows). c Transverse T1-
weighted MR image: The
tumour now shows overall hy-
pointense signal. Calcification
(arrows) is seen as markedly
hyperintense foci. d Transverse
gadolinium-enhanced MR
image: the posterior part of the
tumour is inhomogeneously en-
hancing (arrow). In the anterior
part some small foci of en-
hancement are seen (arrow-
heads)
malignant transformation, as in astrocytic tumours (Fig. 17) T2 WI and iso- to hypointense on T1 WI. Calcification
[23]. can be less conspicuous than on CT, whereas cysts and
Ependymomas originate from the ependymal or sub- small hemorrhagic foci are better demonstrated on MRI.
ependymal cells that line the ventricular walls and the Enhancement is moderate. Fourth ventricular ependymo-
central canal of the spinal cord. Ependymomas are mul- mas fill up the fourth ventricle and show lateral extension
tilobulated, well-demarcated, frequently calcified masses to the cerebellopontine angle cisterns. This is considered
that are by definition intraventricular in location [22]. Most as a major differential diagnostic feature with medullo-
cases occur in the fourth ventricle. They occur most fre- blastoma.
quently in children from 1 to 5 years of age. In adults they Neuronal and mixed neuronal-glial tumours are a rela-
occur in the 3rd decade and are supratentorial. In the tively new group of lesions, based on the detection by new
supratentorial compartment, extraventricular locations are immunohistochemical techniques of neuronal elements in
common (Fig. 18). On non-contrast CT ependymomas are some primary brain tumours. Therefore, in our opinion, it
isodense with calcification in 50%. Enhancement is mild is a specific responsibility for the (neuro-) radiologist to
to moderate. On MR ependymomas are hyperintense on mention these tumours in the differential diagnosis, so that
479
Fig. 19 Dysembryoplastic
neuro-epithelial tumour.
a Transverse T2-weighted
MR-image: in the left parieto-
occipital region a strongly hy-
perintense lesion is seen. There
are some more hypointense
strands in the mass giving rise to
a gyriform pattern. There is no
oedema around the lesion. The
lesion is predominantly located
in the cerebral cortex and causes
a bulging of the surface of the
brain. The overlying bone is
thinned and eroded. b Transverse
gadolinium-enhanced MR
image: There are some spots of
focal enhancement within the
lesion. Notice again the cortical
location, the bulging of the sur-
face of the brain and the erosion
of the bony skull
480
pect of the tumour on gross pathology with cyst formation, arachnoid space is well demonstrated by MRI. Evidence of
haemorrhage and calcification is reflected by its heteroge- leptomeningeal spread is evident in one-third to one-half
neous aspect on imaging studies (Fig. 21a, b). Invasion of the patients (Fig. 21c) [46, 47]. Imaging of the spinal
of the brain stem and extension through the foramen of canal therefore is part of the routine preoperative imaging
Magendie towards the cisterna magna and the spinal sub- protocol of children with tumours of the posterior fossa.
Fig. 21 Medulloblastoma in a 5-year-old child. a Sagittal gadolin- The tumour extends to the inferior cerebellar peduncles, being most
ium-enhanced MR image: huge tumour, originating from the inferior pronounced on the right (arrow). c Sagittal gadolinium-enhanced
vermis with upward displacement of the fourth ventricle. Clear MR image of the spinal canal: presence of a large seeding lesion on
invasion of the brain stem (arrows). Notice seeding to the spinal the surface of the spinal cord
subarachnoid space. b Transverse gadolinium-enhanced MR image:
481
glioblastoma and lymphoma. Besides the distribution of the promising. On diffusion-weighted sequences, the high cel-
lesions, unilateral in glioblastoma, periventricular in lym- lularity of lymphoma is reflected by a restricted diffusion
phoma, the study of the perfusion of these lesions seems (Fig. 25) [4].
References
1. Demaerel P, Beatse E, Roels K, Thijs 5. Lev MH, Ozsunar Y, Henson JW, 9. Stippich C, Kress B, Ochmann H,
V (2001) Intermediate short-term out- Rasheed AA, Barest GD, Harsh GR Tronnier V, Sartor K (2003) Preopera-
comes after brain computed tomogra- 4th, Fitzek MM, Chiocca EA, Rabinov tive functional magnetic resonance
phy and magnetic resonance imaging JD, Csavoy AN, Rosen BR, Hochberg tomography (FMRI) in patients with
in neurology outpatients. Med Decis FH, Schaefer PW, Gonzalez RG (2004) rolandic brain tumors: indication, in-
Making 21(6):444–450 Glial tumor grading and outcome vestigation strategy, possibilities and
2. Demaerel P, Buelens C, Wilms G, prediction using dynamic spin-echo limitations of clinical application. Rofo
Baert AL (1998) Cranial CT revisited: MR susceptibility mapping compared Fortschr Geb Rontgenstr Neuen Bild-
do we really need contrast enhance- with conventional contrast-enhanced geb Verfahr 175(8):1042–1050
ment? Eur Radiol 8(8):1447–1451 MR: confounding effect of elevated 10. Barboriak DP (2003) Imaging of brain
3. Desprechins B, Stadnik T, Koerts G, rCBV of oligodendroglimoas. Am J tumors with diffusion-weighted and
Shabana W, Breucq C, Osteaux M Neuroradiol 25(2):214–221 diffusion tensor MR imaging. Magn
(1999) Use of diffusion-weighted MR 6. Law M, Yang S, Wang H, Babb JS, Reson Imaging Clin N Am 11(3):379–
imaging in differential diagnosis be- Johnson G, Cha S, Knopp EA, Zagzag 401
tween intracerebral necrotic tumors D (2003) Glioma grading: sensitivity, 11. Sinha S, Bastin ME, Whittle IR,
and cerebral abscesses. Am J Neuro- specificity, and predictive values of Wardlaw JM (2002) Diffusion tensor
radiol 20(7):1252–1257 perfusion MR imaging and proton MR MR imaging of high-grade cerebral
4. Stadnik TW, Chaskis C, Michotte A, spectroscopic imaging compared with gliomas. Am J Neuroradiol 23(4):520–
Shabana WM, van Rompaey K, conventional MR imaging. Am J 527
Luypaert R, Budinsky L, Jellus V, Osteaux Neuroradiol 24(10):1989–1998 12. Price SJ, Burnet NG, Donovan T,
M (2001) Diffusion-weighted MR imag- 7. Law M, Yang S, Babb JS, Knopp EA, Green HA, Pena A, Antoun NM,
ing of intracerebral masses: comparison Golfinos JG, Zagzag D, Johnson G Pickard JD, Carpenter TA, Gillard JH
with conventional MR imaging and his- (2004) Comparison of cerebral blood (2003) Diffusion tensor imaging of
tologic findings. Am J Neuroradiol 22 volume and vascular permeability from brain tumours at 3T: a potential tool for
(5):969–976 dynamic susceptibility contrast-en- assessing white matter tract invasion?
hanced perfusion MR imaging with Clin Radiol 58(6):455–462
glioma grade. Am J Neuroradiol 25
(5):746–755
8. Sunaert S, Yousry TA (2001) Clinical
applications of functional magnetic
resonance imaging. Neuroimaging Clin
N Am 11(2):221–236
483
13. Wilms G, Bosmans H, Marchal G, 25. Ginsberg LE, Fuller GN, Hashmi M, 37. Ildan F, Tuna M, Gocer IA, Erman T,
Demaerel P, Goffin J, Plets C, Baert AL Leeds NE, Schomer DF (1998) The Cetinalp E (2001) Intracerebral gangli-
(1995) Magnetic resonance angiogra- significance of lack of MR contrast oglioma: clinical and radiological study
phy of supratentorial tumours: compar- enhancement of supratentorial brain of eleven surgically treated cases with
ison with selective digital subtraction tumors in adults: histopathological follow-up. Neurosurg Rev 24(2–
angiography. Neuroradiology 37(1):42– evaluation of a series. Surg Neurol 49 3):114–118
47 (4):436–440 38. Ostertun B, Wolf HK, Campos MG,
14. Wilms G, Bosmans H, Demaerel P, 26. Sugahara T, Korogi Y, Tomiguchi S, Matus C, Solymosi L, Elger CE,
Marchal G (2001) Magnetic resonance Shigematsu Y, Ikushima I, Kira T, Schramm J, Schild HH (1996) Dysem-
angiography of the intracranial vessels. Liang L, Ushio Y, Takahashi M (2000) bryoplastic neuroepithelial tumors: MR
Eur J Radiol 38(1):10–18 (Review) Posttherapeutic intraaxial brain tumor: and CT evaluation. Am J Neuroradiol
15. Akeson P, Larsson EM, Kristoffersen the value of perfusion-sensitive con- 17:419–430
DT, Jonsson E, Holtas S (1995) Brain trast-enhanced MR imaging for differ- 39. Stanescu Cosson R, Varlet P, Beuvon F,
metastases-comparison of gadodiamide entiating tumor recurrence from Daumas Duport C, Devaux B,
injection-enhanced MR imaging at nonneoplastic contrast-enhancing tis- Chassoux F, Fredy D, Meder JF (2001)
standard and high dose, contrast-en- sue. Am J Neuroradiol 21(5):901–909 Dysembryoplastic neuroepithelial tu-
hanced CT and non-contrast-enhanced 27. Smith JK, Castillo M, Kwock L (2003) mors: CT, MR findings and imaging
MR imaging. Acta Radiol 36(3):300– MR spectroscopy of brain tumors. follow-up: a study of 53 cases. J
306 Magn Reson Imaging Clin N Am 11 Neuroradiol 28(4):230–240
16. Yuh WTC, Tali ET, Nguyen HD, (3):415–429 40. Goergen SK, Gonzales MF, McLean
Simonson TM, Mayr NA, Fisher DJ 28. Kleihues P, Burger PC, Scheithauer CA (1992) Intraventricular neurocyto-
(1995) The effect of contrast dose, BW (1993) Histological typing of ma: radiologic features and review of
imaging time, and lesion size in the MR tumours of the central nervous system, the literature. Radiol 182:787–792
detection of intracerebral metastasis. 2nd edn. Springer, Berlin Heidelberg 41. Jelinek J, Smirniotopoulos JG, Parisi
Am J Neuroradiol 16:373–380 New York JE, Kanzer M (1990) Lateral ventricu-
17. Hahnel S, Jost G, Knauth M, Sartor K 29. Kleihues P, Cavenee WK (2000) Pa- lar neoplasms of the brain: differential
(2004) Current use and possible future thology and genetics of tumours of the diagnosis based on clinical, CT, and
applications of the magnetization nervous system. IARC, Lyon MR findings. Am J Neuroradiol
transfer technique in neuroradiology. 30. Schneider SW, Ludwig T, Tatenhorst L, 11:567–574
Rofo Fortschr Geb Rontgenstr Neuen Braune S, Oberleithner H, Senner V, 42. Robles HA, Smirniotopoulos JG,
Bildgeb Verfahr 176(2):175–182 Paulus W (2004) Glioblastoma cells Figueroa RE (1992) Understanding the
18. Goel A (2002) Tumour induced hy- release factors that disrupt blood-brain radiology of intracranial primitive neu-
drocephalus and oedema: pathology or barrier features. Acta Neuropathol roectodermal tumors from a patholog-
natural defence. J Postgrad Med 48 (Berl) 107(3):272–276 ical perspective: a review. Sem US CT
(2):153–154 31. Nagashima G, Suzuki R, Asai JI, Noda MR 13:170–181
19. Goraj B, Spiller M, Valsamis MP, M, Fujimoto M, Fujimoto T (2003) 43. Mueller DP, Moore SA, Sato Y, Yuh
Kasoff SS, Tenner MS (1995) Deter- Tissue reconstruction process in the WTC (1992) MRI spectrum of medul-
minants of signal intensity in MRI of area of peri-tumoural oedema caused loblastoma. Clinical Imaging 16:250–
human astrocytomas. Eur Radiol 5:74– by glioblastoma-immunohistochemical 255
82 and graphical analysis using brain 44. Tortori-Donati P, Fondelli MP, Rossi A,
20. Dean BL, Drayer BP, Bird CR, Flom obtained at autopsy. Acta Neurochir Cama A, Caputo L, Andreussi L,
RA, Hodak JA, Coons SW, Carey RG Suppl 86:507–511 Garré ML (1996) Medullo-
(1990) Gliomas: classification with MR 32. Fulham MJ, Melisi JW, Nishimiya J, blastoma in children: CT and MRI
imaging. Radiology 174:411–415 Dwyer AJ, Di Chiro G (1993) Neu- findings. Neuroradiology 38:352–359
21. Coates TL, Hinshaw DB, Peckman N, roimaging of juvenile pilocytic astro- 45. Koeller KK, Rushing EJ (2003) From
Thompson JR, Hasso AN, Holshouser cytomas: an enigma. Radiology the archives of the AFIP: medulloblas-
BA, Knierim DS (1989) Pediatric 189:221–225 toma: a comprehensive review with
choroid plexus neoplasms: MR, CT, 33. Lee YY, Van Tassel P, Bruner JM, radiologic-pathologic correlation.
and pathologic correlation. Radiology Moser RP, Share JC (1989) Juvenile Radiographics 23(6):1613–1637
173:81–88 pilocytic astrocytomas: CT and MR 46. Kochi M, Mihara Y, Takada A, Yatomi
22. Spoto GP, Press GA, Hesselink JR, characteristics. Am J Neuroradiol C, Morioka M, Yamashiro S, Yano S,
Solomon M (1990) Intracranial epen- 10:363–370 Kuratsu J, Uemura S, Ushio Y (1991)
dymoma and subependymoma: MR 34. Lee YY, Van Tassel P (1989) Intracra- MRI of subarachnoid dissemination of
manifestations. Am J Neuroradiol nial oligodendrogliomas: imaging medulloblastoma. Neuroradiology
11:83–91 findings in 35 untreated cases. Am J 33:264–268
23. Reiche W, Grunwald I, Hermann K, Neuroradiol 10:119–127 47. Griffiths PD, Coley SC, Romanowski
Deinzer M, Reith W (2002) Oligoden- 35. Blatt GL, Ahuja A, Miller LL, Ostrow CA, Hodgson T, Wilkinson ID (2003)
drogliomas. Acta Radiol 43(5):474– PT, Soloniuk DS (1995) Cerebello- Contrast-enhanced fluid-attenuated in-
482 medullary ganglioglioma: CT and MR version recovery imaging for leptome-
24. Asari S, Makabe T, Katayama S, Itoh T, findings. Am J Neuroradiol 16:790– ningeal disease in children. Am J
Tsuchida S, Ohmoto T (1994) Assess- 792 Neuroradiol 24(4):719–723
ment of the pathological grade of 36. Castillo M, Davis PC, Takei Y,
astrocytic gliomas using an MRI score. Hoffman JC (1990) Intracranial gan-
Neuroradiology 36:308–310 glioglioma: MR, CT, and clinical find-
ings in 18 patients. Am J Neuroradiol
11:109–114
484
48. Malheiros SM, Carrete H Jr, Stavale 50. Carrier DA, Mawad ME, Kirkpatrick 52. Law M, Cha S, Knopp EA, Johnson G,
JN, Santos AJ, Borges LR, Guimaraes JB, Schmid MF (1994) Metastatic ad- Arnett J, Litt AW (2002) High-grade
IF, Pelaez MP, Franco CM, Gabbai AA enocarcinoma to the brain: MR with gliomas and solitary metastases: differ-
(2003) MRI of medulloblastoma in pathologic correlation. Am J Neuro- entiation by using perfusion and proton
adults. Neuroradiology 45(7):463–467 radiol 15:155–159 spectroscopic MR imaging. Radiology
49. Sawaya R (2001) Considerations in the 51. Kremer S, Grand S, Berger F, 222(3):715–721
diagnosis and management of brain Hoffmann D, Pasquier B, Remy C,
metastases. Oncology (Huntingt) 15 Benabid AL, Bas JF (2003) Dynamic
(9):1144–1154 (See also pages 1157– contrast-enhanced MRI: differentiating
1158 Discussion 1158, 1163–1165) melanoma and renal carcinoma metas-
tases from high-grade astrocytomas and
other metastases. Neuroradiology 45
(1):44–49